Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) - Related Studies

Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

This study has been completed.

Study NCT00344513. Last updated on October 13, 2008. Information provided by GlaxoSmithKline

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Heart Failure

2	More general conditions related to this trial
		Cardiovascular Diseases
		Heart Diseases

3	Interventions listed in this trial
		Beta-blockers including Carvedilol
		ACE inhibitors

4	Additional drug interventions recognized in this trial
		Carvedilol

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic alpha-Antagonists
		Adrenergic Antagonists
		Adrenergic beta-Antagonists
		Antihypertensive Agents
		Cardiovascular Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses
		Vasodilator Agents

6	Sponsors listed in this trial
		GlaxoSmithKline